PRKN and ovarian cancer: We discovered that the upregulation of the LC3II/LC3I ratio and the expression of PINK1 and Parkin could be inhibited by HCQ (Fig. 2c–f), further proving that ovarian cancer cell-derived EVs could trigger the mitophagy in endothelial cells.